This report contains market size and forecasts of Duchenne Muscular Dystrophy (DMD) Therapeutics in Global, including the following market information:
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Duchenne Muscular Dystrophy (DMD) Therapeutics market was valued at 962.5 million in 2020 and is projected to reach US$ 3728.2 million by 2027, at a CAGR of 40.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy (DMD) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
ALSO READ : http://www.marketwatch.com/story/duchenne-muscular-dystrophy-therap...
Total Market by Segment:
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segment Percentages, By Type, 2020 (%)
Exondys
Emflaza
Translarna
China Duchenne Muscular Dystrophy (DMD) Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Home Care
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-statistical-an...
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-rna-int...
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Duchenne Muscular Dystrophy (DMD) Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Duchenne Muscular Dystrophy (DMD) Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-aluminu...
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Duchenne Muscular Dystrophy (DMD) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Overall Market Size
2.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size: 2021 VS 2027
2.2 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-pc-serv...
3.1 Top Duchenne Muscular Dystrophy (DMD) Therapeutics Players in Global Market
3.2 Top Global Duchenne Muscular Dystrophy (DMD) Therapeutics Companies Ranked by Revenue
3.3 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Duchenne Muscular Dystrophy (DMD) Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Duchenne Muscular Dystrophy (DMD) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy (DMD) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Duchenne Muscular Dystrophy (DMD) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Duchenne Muscular Dystrophy (DMD) Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Exondys
4.1.3 Emflaza
4.1.4 Translarna
4.2 By Type - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Care
5.2 By Application - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2016-2027
6.3.2 US Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.3.3 Canada Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.3.4 Mexico Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2016-2027
6.4.2 Germany Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.4.3 France Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.4.4 U.K. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.4.5 Italy Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.4.6 Russia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.4.8 Benelux Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2016-2027
6.5.2 China Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.5.3 Japan Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.5.4 South Korea Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.5.6 India Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2016-2027
6.6.2 Brazil Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.6.3 Argentina Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue, 2016-2027
6.7.2 Turkey Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.7.3 Israel Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
6.7.5 UAE Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Sarepta Therapeutics
7.1.1 Sarepta Therapeutics Corporate Summary
7.1.2 Sarepta Therapeutics Business Overview
7.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Major Product Offerings
7.1.4 Sarepta Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue in Global (2016-2021)
7.1.5 Sarepta Therapeutics Key News
7.2 PTC Therapeutics
7.2.1 PTC Therapeutics Corporate Summary
7.2.2 PTC Therapeutics Business Overview
7.2.3 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Major Product Offerings
7.2.4 PTC Therapeutics Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue in Global (2016-2021)
7.2.5 PTC Therapeutics Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Major Product Offerings
7.3.4 Pfizer Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Major Product Offerings
7.4.4 Bristol-Myers Squibb Duchenne Muscular Dystrophy (DMD) Therapeutics Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Key News
7.5 Italfarmaco
....continued
CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105